Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (77)

2024

  1. A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants

    Journal of Infectious Diseases, Vol. 229, pp. S112-S119

  2. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

  4. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  5. Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 161-170

  6. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

    Nature Communications, Vol. 15, Núm. 1

2023

  1. A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)

    Vaccine, Vol. 41, Núm. 21, pp. 3387-3398

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Addressing influenza’s underestimated burden – Iberian experts call to action

    BMC Infectious Diseases

  4. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

    Journal of Infection, Vol. 87, Núm. 6, pp. 538-550

  5. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  6. Challenges and unmet needs in FPIES from the parents and adult patients’ perspective: An international survey

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 4, pp. 1306-1309.e2

  7. Chatting with ChatGPT to learn about safety of COVID-19 vaccines–A perspective

    Human Vaccines and Immunotherapeutics

  8. Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

  9. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  10. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

  11. Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 49

  12. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe

    Vaccine, Vol. 41, Núm. 16, pp. 2707-2715

  13. Erratum: Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 (Nature (2023) 617 7962 (764-768))

    Nature

  14. Erratum: Correction to: Febrile illness in high-risk children: a prospective, international observational study (European journal of pediatrics (2023) 182 2 (543-554))

    European journal of pediatrics